Relative Bioavailability and Tolerability of Various Experimental Formulations of BIBV 308 SE in Healthy Subjects

NCT02223000 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

9

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: BIBV 308 SE solution
DRUG: BIBV 308 SE capsule 1
DRUG: BIBV 308 SE capsule 2

Sponsor

Boehringer Ingelheim